Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Novartis
Kivu Bioscience Inc.
Hoffmann-La Roche
Institut Bergonié
City of Hope Medical Center
Aveni Foundation
Bayer
University of California, Irvine
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
ViroMissile, Inc.
Dana-Farber Cancer Institute
Kaiser Permanente
AstraZeneca
Washington University School of Medicine
University of Florida
Essen Biotech
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
MacroGenics
Indiana University
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
City of Hope Medical Center
Fred Hutchinson Cancer Center
University of Nebraska
Adela, Inc
Perspective Therapeutics
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Ocellaris Pharma, Inc.
Indiana University
Eli Lilly and Company
Var2 Pharmaceuticals
M.D. Anderson Cancer Center
UNICANCER
Memorial Sloan Kettering Cancer Center
Mayo Clinic
Tanabe Pharma America, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
HiFiBiO Therapeutics
Seattle Children's Hospital
Seattle Children's Hospital
Tango Therapeutics, Inc.
Bayer